Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.

Abstract

Low dose HHT alone showed considerable short term and long term efficacy in the treatment of late stage CML. It may also be a good choice for patients who have failed imatinib, IFN-alpha treatment or haematopoietic stem cell transplantation or cannot afford these treatments.